Is Trelegy a Steroid Inhaler for COPD and Asthma?

Yes. Trelegy is a combination inhaler that contains an inhaled corticosteroid, called fluticasone furoate, along with two long-acting bronchodilators. For many people, it is used safely as a daily maintenance medicine for chronic obstructive pulmonary disease (COPD) or certain cases of asthma when prescribed and monitored by a clinician.

Is Trelegy a Steroid? The Short Answer

Yes. Trelegy Ellipta is a combination inhaler that includes an inhaled corticosteroid (ICS), fluticasone furoate. It also contains two long-acting bronchodilators: umeclidinium, a long-acting muscarinic antagonist, and vilanterol, a long-acting beta₂-agonist. Together, these medicines help reduce inflammation, relax airway muscles, and support more open airways over time.

For most people using it as prescribed, the corticosteroid is intended to act primarily in the airways and is generally not associated with the whole-body effects commonly linked with repeated or high-dose steroid tablets. However, all medicines can have side effects, and regular review remains important. Trelegy is used as daily maintenance treatment for COPD and, in appropriate patients, asthma; it is not a rescue inhaler for sudden breathlessness.

Understanding that Trelegy contains a steroid can make its role clearer. The corticosteroid targets airway inflammation, while the other two ingredients address airway narrowing. A clinician can help decide whether this three-medicine approach matches a person’s diagnosis, symptoms, exacerbation history, and other health conditions.

What the Three Medicines in Trelegy Do

Fluticasone furoate is the inhaled corticosteroid component. Inflammation can make the airways sensitive, swollen, and more likely to produce mucus. By reducing inflammation, an inhaled corticosteroid can help lower the risk of asthma flare-ups in suitable patients and may have a role in selected people with COPD who have repeated exacerbations or features suggesting steroid responsiveness.

Umeclidinium is a long-acting muscarinic antagonist, sometimes called a LAMA. It helps prevent tightening of the muscles around the airways. Vilanterol is a long-acting beta₂-agonist, or LABA, which also relaxes airway muscles through a different pathway. These medicines work over many hours, which is why Trelegy is designed for regular daily use rather than immediate symptom relief.

The three components are delivered together in one inhaler, which may simplify a treatment plan for some patients. The most appropriate inhaler depends on the condition being treated, current symptom control, previous exacerbations, inhaler technique, and individual risks. A person should not start, stop, or share Trelegy without advice from a qualified clinician.

Trelegy, Oral Steroids, and Rescue Inhalers: Important Differences

The word “steroid” can describe several different medicines. Trelegy’s steroid is inhaled, so much of the medicine is deposited in the lungs. This differs from oral corticosteroids, such as prednisolone, which circulate throughout the body and are often used for a short time during a significant asthma or COPD exacerbation. Oral steroids can be very helpful when indicated, but their risk of systemic side effects is generally greater, particularly with prolonged or repeated use.

Trelegy is also different from a quick-relief or rescue inhaler. Rescue inhalers contain fast-acting bronchodilators and are intended to ease sudden wheeze, chest tightness, or shortness of breath. Trelegy does not work quickly enough for an acute breathing emergency. People should follow their personalized action plan and ensure they know which inhaler to use if symptoms begin suddenly.

In COPD, treatment plans often include inhalers that open the airways, with an inhaled corticosteroid added for certain patients. More information about the condition is available in this overview of chronic obstructive pulmonary disease. In asthma, inhaled corticosteroids are a central part of treatment because inflammation is a key feature of the disease, but the best regimen should be tailored by a clinician.

Possible Side Effects and Practical Ways to Reduce Them

Many people tolerate Trelegy well, but side effects are possible. Because it contains an inhaled corticosteroid, it can increase the chance of oral thrush, a yeast infection in the mouth or throat. Symptoms may include white patches, soreness, changes in taste, or discomfort when eating. Hoarseness and throat irritation can also occur.

Rinsing the mouth with water and spitting it out after each dose is a simple step that can help reduce local steroid-related effects. Taking Trelegy exactly as instructed and checking inhaler technique with a pharmacist, nurse, or doctor can also improve delivery of the medicine and reduce avoidable problems.

The bronchodilator ingredients may cause effects such as dry mouth, headache, tremor, awareness of the heartbeat, or difficulty passing urine in some people. People with glaucoma, urinary retention, heart rhythm concerns, or certain other medical conditions should make sure their prescriber knows their full medical history and all medicines they use. In people with COPD, inhaled corticosteroids may be associated with an increased risk of pneumonia, so respiratory symptoms that change noticeably should be reviewed rather than assumed to be routine.

• Do not use extra doses to treat sudden breathlessness.
• Do not stop a prescribed maintenance inhaler abruptly without discussing it with the prescriber.
• Tell the clinical team about repeated mouth infections, persistent voice changes, or troublesome side effects.
• Bring the inhaler to appointments so technique and adherence can be checked.

When to Seek Medical Care

Mild throat irritation or a dry mouth may be manageable with correct technique and mouth rinsing, but new symptoms should still be discussed if they persist or interfere with daily life. A clinician should review frequent use of a rescue inhaler, waking at night with breathing symptoms, reduced ability to exercise, or repeated flare-ups. These may indicate that the current treatment plan, diagnosis, inhaler technique, or trigger control needs reassessment.

Urgent medical care is needed for severe or rapidly worsening shortness of breath, difficulty speaking in full sentences, blue or gray lips, confusion, severe chest pain, or symptoms that do not improve with a prescribed rescue treatment. Emergency help is also appropriate for signs of a serious allergic reaction, including swelling of the face, mouth, or throat; widespread hives; or trouble breathing.

Fever, worsening cough, increased mucus, a change in mucus color, chest discomfort, or feeling unusually unwell can sometimes suggest a respiratory infection, including pneumonia. This is particularly important for people with COPD who use an inhaled corticosteroid. Prompt assessment allows a clinician to determine the cause and recommend appropriate care.

How a Doctor Reviews Whether Trelegy Is Appropriate

When reviewing a person who uses Trelegy, a doctor will usually begin by clarifying the respiratory diagnosis and asking about symptoms, activity limitation, flare-ups, hospital visits, smoking or exposure history, allergies, and other medical conditions. They will also review medicines, including eye drops, heart medicines, supplements, and other inhalers, to identify potential interactions or duplicated treatment.

Assessment may include listening to the lungs, checking oxygen levels when appropriate, and observing inhaler technique. Lung function testing, such as spirometry, can help assess airflow limitation and support the diagnosis of asthma or COPD. Depending on symptoms, a clinician may arrange blood tests, chest imaging, or tests for infection, heart conditions, or other causes of breathlessness.

Medication choices are not based on one symptom alone. A clinician weighs expected benefits against risks, including previous exacerbations, eosinophil results where relevant in COPD, history of pneumonia, and the person’s ability to use the device consistently. The aim is to find the lowest-complexity plan that provides reliable control and reduces future risk.

Safe Daily Use and Ongoing Respiratory Care

Trelegy should be taken only in the dose and schedule prescribed, usually once daily. It should be used consistently even when a person feels well, unless the prescriber recommends a change. Missing doses, taking more than prescribed, or using another long-acting inhaler at the same time without medical advice can increase the risk of unwanted effects.

People with asthma or COPD can also benefit from a written action plan that explains regular medicines, early signs of worsening control, rescue treatment, and when to seek urgent help. Avoiding tobacco smoke and other airway irritants, staying physically active within personal limits, receiving recommended vaccinations, and attending follow-up appointments are important parts of respiratory health.

Acıbadem Health Point’s multidisciplinary specialists and JCI-accredited hospitals can assess asthma and COPD, review inhaler technique, and develop individualized treatment plans for international patients. Any medication changes should be made with a qualified doctor who has access to the person’s full medical history.

Frequently asked questions